Alto Neuroscience, Inc.

US$25.16As of Sun 8 Nov 2026, 12:00 UTC
NYSE:ANROHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR 20.01%
Div yield —
ROE (49.17%)
Biotechnology
Beta (5Y) 1.45
PE TTM —
TSR TTM 77.31%
Mkt cap US$987.3M
ROIC (28.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$25
(0.05%)
(68.21%)
Buy 12|0|5|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.48
0.52
0.53
0.56
15.45%
15.61%
14.51%
12.09%
Revenue$M
99.73
97.78
103.6
104.1
5.43%
(1.45%)
4.52%
3.25%
Peers (US$987.3M)
Cap (US$)
PE
1.060B
—
Capital
TTM
5Y
10Y
Leveragex
3.176
2.331
1.691
EBIT/Intx
2.678
0.102
0.137
Own earn%
78.49
27.08
28.16
Sh yield%
29.78
18.35
18.62
Owners
Insiders/Inst%
4.60
47.70
Short interest%
2.18
SBC / revenue%
3.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
4